Originally published October 4 2005
Strattera may increase risk of suicidal thoughts
by Mike Adams, the Health Ranger, NaturalNews Editor
Strattera, a drug designed to treat attention deficit hyperactivity disorder, has doctors issuing warnings about possible side effects after 11 cases of children with suicidal thoughts have created widespread concern about the drug.
The Medicines and Healthcare Products Regulatory Agency is warning doctors to be on the look out for warning signs.
For the majority of children on Strattera (atomoxetine), the drug's benefits outweigh any risk and they should continue on the treatment, they said.
Doctors and patients, together with parents and guardians, are being advised of this risk and should be made aware of any possible signs and symptoms as a precautionary measure.
The news follows recent reports of concerns about potential suicidal side effects of commonly used antidepressants among children and teenagers.
Dr June Raine of the MHRA said: "We are advising healthcare professionals that patients should be carefully monitored for signs of depression, suicidal thoughts or suicidal behaviour and referred for alternative treatment if necessary.
The drug is one of many used to help control the symptoms of ADHD - inability to pay attention and impulsiveness and hyperactivity.
Andrea Bilbow, chief executive of the ADHD charity ADDISS, said: "The risk is very small.
If a child is on Strattera and doing well, don't stop.
"If they are concerned, they should go and discuss this with their doctor.
And doctors should be screening users for suicidal thoughts."
She said because of the nature of ADHD, many children with the condition were already vulnerable and at risk of suicidal thoughts and should be monitored regularly anyway.
"These kids what ever drug they are on do need to be monitored more often."
The drug's manufacturer Eli Lilly said that while suicidal thinking was uncommon in patients on the medication during clinical trials, it was important for parents to be aware that it can occur and to discuss any unusual symptoms with their child's doctor.
All content posted on this site is commentary or opinion and is protected under Free Speech. Truth Publishing LLC takes sole responsibility for all content. Truth Publishing sells no hard products and earns no money from the recommendation of products. NaturalNews.com is presented for educational and commentary purposes only and should not be construed as professional advice from any licensed practitioner. Truth Publishing assumes no responsibility for the use or misuse of this material. For the full terms of usage of this material, visit www.NaturalNews.com/terms.shtml